nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—SLC22A5—Dactinomycin—skin cancer	0.191	0.288	CbGbCtD
Histamine Phosphate—CYP2C9—Vismodegib—skin cancer	0.095	0.144	CbGbCtD
Histamine Phosphate—CYP3A4—Imiquimod—skin cancer	0.0797	0.12	CbGbCtD
Histamine Phosphate—CYP3A4—Temozolomide—skin cancer	0.0797	0.12	CbGbCtD
Histamine Phosphate—CYP2D6—Vemurafenib—skin cancer	0.0687	0.104	CbGbCtD
Histamine Phosphate—CYP3A4—Vismodegib—skin cancer	0.0553	0.0835	CbGbCtD
Histamine Phosphate—CYP3A4—Vemurafenib—skin cancer	0.0437	0.066	CbGbCtD
Histamine Phosphate—CYP2C9—Fluorouracil—skin cancer	0.0338	0.051	CbGbCtD
Histamine Phosphate—CYP3A4—Docetaxel—skin cancer	0.015	0.0227	CbGbCtD
Histamine Phosphate—HRH1—nose—skin cancer	0.00601	0.144	CbGeAlD
Histamine Phosphate—Risedronate—PTGS2—skin cancer	0.00307	1	CrCbGaD
Histamine Phosphate—CA4—nerve—skin cancer	0.00249	0.0598	CbGeAlD
Histamine Phosphate—HNMT—connective tissue—skin cancer	0.00236	0.0568	CbGeAlD
Histamine Phosphate—HNMT—epithelium—skin cancer	0.00224	0.0539	CbGeAlD
Histamine Phosphate—HRH3—head—skin cancer	0.00176	0.0424	CbGeAlD
Histamine Phosphate—HNMT—female reproductive system—skin cancer	0.00167	0.04	CbGeAlD
Histamine Phosphate—HRH2—skin of body—skin cancer	0.00165	0.0397	CbGeAlD
Histamine Phosphate—SLC22A3—nipple—skin cancer	0.00159	0.0381	CbGeAlD
Histamine Phosphate—CA4—nipple—skin cancer	0.00141	0.034	CbGeAlD
Histamine Phosphate—CA4—neck—skin cancer	0.0014	0.0336	CbGeAlD
Histamine Phosphate—HNMT—head—skin cancer	0.00139	0.0335	CbGeAlD
Histamine Phosphate—SLC22A5—nipple—skin cancer	0.00115	0.0277	CbGeAlD
Histamine Phosphate—SLC22A3—connective tissue—skin cancer	0.00112	0.027	CbGeAlD
Histamine Phosphate—HRH2—head—skin cancer	0.00108	0.0259	CbGeAlD
Histamine Phosphate—HRH1—nipple—skin cancer	0.000977	0.0235	CbGeAlD
Histamine Phosphate—HNMT—lymph node—skin cancer	0.000974	0.0234	CbGeAlD
Histamine Phosphate—SLC22A3—mammalian vulva—skin cancer	0.000926	0.0223	CbGeAlD
Histamine Phosphate—SLC22A3—female reproductive system—skin cancer	0.000793	0.0191	CbGeAlD
Histamine Phosphate—HRH2—lymph node—skin cancer	0.000753	0.0181	CbGeAlD
Histamine Phosphate—SLC22A5—skin of body—skin cancer	0.000738	0.0177	CbGeAlD
Histamine Phosphate—CA4—female reproductive system—skin cancer	0.000707	0.017	CbGeAlD
Histamine Phosphate—HRH1—connective tissue—skin cancer	0.000693	0.0167	CbGeAlD
Histamine Phosphate—SLC22A1—head—skin cancer	0.000693	0.0167	CbGeAlD
Histamine Phosphate—SLC22A3—head—skin cancer	0.000662	0.0159	CbGeAlD
Histamine Phosphate—HRH1—epithelium—skin cancer	0.000658	0.0158	CbGeAlD
Histamine Phosphate—Hypoaesthesia—Temozolomide—skin cancer	0.000639	0.00218	CcSEcCtD
Histamine Phosphate—Chills—Dactinomycin—skin cancer	0.000637	0.00217	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Temozolomide—skin cancer	0.000633	0.00216	CcSEcCtD
Histamine Phosphate—Pruritus—Vemurafenib—skin cancer	0.000632	0.00215	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Temozolomide—skin cancer	0.000631	0.00215	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Imiquimod—skin cancer	0.000628	0.00214	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Imiquimod—skin cancer	0.000623	0.00212	CcSEcCtD
Histamine Phosphate—Erythema—Dactinomycin—skin cancer	0.000618	0.00211	CcSEcCtD
Histamine Phosphate—Pain in extremity—Docetaxel—skin cancer	0.000617	0.0021	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Bleomycin—skin cancer	0.000615	0.00209	CcSEcCtD
Histamine Phosphate—Anaemia—Bleomycin—skin cancer	0.000613	0.00209	CcSEcCtD
Histamine Phosphate—Diarrhoea—Vemurafenib—skin cancer	0.000611	0.00208	CcSEcCtD
Histamine Phosphate—Urticaria—Imiquimod—skin cancer	0.000605	0.00206	CcSEcCtD
Histamine Phosphate—Body temperature increased—Imiquimod—skin cancer	0.000602	0.00205	CcSEcCtD
Histamine Phosphate—Abdominal pain—Imiquimod—skin cancer	0.000602	0.00205	CcSEcCtD
Histamine Phosphate—Malaise—Bleomycin—skin cancer	0.000598	0.00204	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Temozolomide—skin cancer	0.000596	0.00203	CcSEcCtD
Histamine Phosphate—Flushing—Temozolomide—skin cancer	0.000596	0.00203	CcSEcCtD
Histamine Phosphate—Leukopenia—Bleomycin—skin cancer	0.000593	0.00202	CcSEcCtD
Histamine Phosphate—Dizziness—Vemurafenib—skin cancer	0.00059	0.00201	CcSEcCtD
Histamine Phosphate—CA4—head—skin cancer	0.00059	0.0142	CbGeAlD
Histamine Phosphate—Hypoaesthesia—Fluorouracil—skin cancer	0.000589	0.00201	CcSEcCtD
Histamine Phosphate—Angiopathy—Temozolomide—skin cancer	0.000583	0.00198	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Temozolomide—skin cancer	0.000579	0.00197	CcSEcCtD
Histamine Phosphate—Cough—Bleomycin—skin cancer	0.000578	0.00197	CcSEcCtD
Histamine Phosphate—SLC22A5—female reproductive system—skin cancer	0.000576	0.0139	CbGeAlD
Histamine Phosphate—Chills—Temozolomide—skin cancer	0.000576	0.00196	CcSEcCtD
Histamine Phosphate—Dehydration—Docetaxel—skin cancer	0.000574	0.00196	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Dactinomycin—skin cancer	0.000574	0.00195	CcSEcCtD
Histamine Phosphate—Anaemia—Dactinomycin—skin cancer	0.000571	0.00195	CcSEcCtD
Histamine Phosphate—HRH1—mammalian vulva—skin cancer	0.000571	0.0137	CbGeAlD
Histamine Phosphate—Vomiting—Vemurafenib—skin cancer	0.000568	0.00193	CcSEcCtD
Histamine Phosphate—Dry skin—Docetaxel—skin cancer	0.000566	0.00193	CcSEcCtD
Histamine Phosphate—Myalgia—Bleomycin—skin cancer	0.000564	0.00192	CcSEcCtD
Histamine Phosphate—Chest pain—Bleomycin—skin cancer	0.000564	0.00192	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Docetaxel—skin cancer	0.000564	0.00192	CcSEcCtD
Histamine Phosphate—Rash—Vemurafenib—skin cancer	0.000563	0.00192	CcSEcCtD
Histamine Phosphate—Mental disorder—Temozolomide—skin cancer	0.000563	0.00192	CcSEcCtD
Histamine Phosphate—Dermatitis—Vemurafenib—skin cancer	0.000562	0.00192	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Imiquimod—skin cancer	0.000561	0.00191	CcSEcCtD
Histamine Phosphate—Headache—Vemurafenib—skin cancer	0.000559	0.00191	CcSEcCtD
Histamine Phosphate—Erythema—Temozolomide—skin cancer	0.000559	0.0019	CcSEcCtD
Histamine Phosphate—Malnutrition—Temozolomide—skin cancer	0.000559	0.0019	CcSEcCtD
Histamine Phosphate—Discomfort—Bleomycin—skin cancer	0.000558	0.0019	CcSEcCtD
Histamine Phosphate—Malaise—Dactinomycin—skin cancer	0.000557	0.0019	CcSEcCtD
Histamine Phosphate—Cramp muscle—Docetaxel—skin cancer	0.000556	0.00189	CcSEcCtD
Histamine Phosphate—Leukopenia—Dactinomycin—skin cancer	0.000553	0.00188	CcSEcCtD
Histamine Phosphate—Dysgeusia—Temozolomide—skin cancer	0.000548	0.00186	CcSEcCtD
Histamine Phosphate—Asthenia—Imiquimod—skin cancer	0.000546	0.00186	CcSEcCtD
Histamine Phosphate—Confusional state—Bleomycin—skin cancer	0.000545	0.00186	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Bleomycin—skin cancer	0.000541	0.00184	CcSEcCtD
Histamine Phosphate—Back pain—Temozolomide—skin cancer	0.000541	0.00184	CcSEcCtD
Histamine Phosphate—Pruritus—Imiquimod—skin cancer	0.000539	0.00183	CcSEcCtD
Histamine Phosphate—Infection—Bleomycin—skin cancer	0.000537	0.00183	CcSEcCtD
Histamine Phosphate—Dysphagia—Docetaxel—skin cancer	0.000534	0.00182	CcSEcCtD
Histamine Phosphate—Nausea—Vemurafenib—skin cancer	0.00053	0.00181	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Bleomycin—skin cancer	0.00053	0.0018	CcSEcCtD
Histamine Phosphate—Arrhythmia—Fluorouracil—skin cancer	0.000529	0.0018	CcSEcCtD
Histamine Phosphate—Myalgia—Dactinomycin—skin cancer	0.000526	0.00179	CcSEcCtD
Histamine Phosphate—Bronchospasm—Docetaxel—skin cancer	0.000525	0.00179	CcSEcCtD
Histamine Phosphate—Diarrhoea—Imiquimod—skin cancer	0.000521	0.00177	CcSEcCtD
Histamine Phosphate—Discomfort—Dactinomycin—skin cancer	0.00052	0.00177	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Temozolomide—skin cancer	0.000519	0.00177	CcSEcCtD
Histamine Phosphate—Anaemia—Temozolomide—skin cancer	0.000517	0.00176	CcSEcCtD
Histamine Phosphate—Anorexia—Bleomycin—skin cancer	0.000516	0.00176	CcSEcCtD
Histamine Phosphate—Erythema—Fluorouracil—skin cancer	0.000515	0.00175	CcSEcCtD
Histamine Phosphate—Hypotension—Bleomycin—skin cancer	0.000506	0.00172	CcSEcCtD
Histamine Phosphate—Malaise—Temozolomide—skin cancer	0.000504	0.00172	CcSEcCtD
Histamine Phosphate—Dizziness—Imiquimod—skin cancer	0.000504	0.00172	CcSEcCtD
Histamine Phosphate—Vertigo—Temozolomide—skin cancer	0.000502	0.00171	CcSEcCtD
Histamine Phosphate—Infection—Dactinomycin—skin cancer	0.000501	0.00171	CcSEcCtD
Histamine Phosphate—Leukopenia—Temozolomide—skin cancer	0.000501	0.0017	CcSEcCtD
Histamine Phosphate—Neutropenia—Docetaxel—skin cancer	0.000499	0.0017	CcSEcCtD
Histamine Phosphate—CYP2C9—female reproductive system—skin cancer	0.000496	0.0119	CbGeAlD
Histamine Phosphate—Palpitations—Temozolomide—skin cancer	0.000494	0.00168	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Dactinomycin—skin cancer	0.000494	0.00168	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000493	0.00168	CcSEcCtD
Histamine Phosphate—HRH1—female reproductive system—skin cancer	0.000489	0.0118	CbGeAlD
Histamine Phosphate—Cough—Temozolomide—skin cancer	0.000488	0.00166	CcSEcCtD
Histamine Phosphate—Paraesthesia—Bleomycin—skin cancer	0.000486	0.00165	CcSEcCtD
Histamine Phosphate—Weight increased—Docetaxel—skin cancer	0.000486	0.00165	CcSEcCtD
Histamine Phosphate—Convulsion—Temozolomide—skin cancer	0.000484	0.00165	CcSEcCtD
Histamine Phosphate—Vomiting—Imiquimod—skin cancer	0.000484	0.00165	CcSEcCtD
Histamine Phosphate—Weight decreased—Docetaxel—skin cancer	0.000483	0.00164	CcSEcCtD
Histamine Phosphate—Hypertension—Temozolomide—skin cancer	0.000483	0.00164	CcSEcCtD
Histamine Phosphate—Dyspnoea—Bleomycin—skin cancer	0.000482	0.00164	CcSEcCtD
Histamine Phosphate—Anorexia—Dactinomycin—skin cancer	0.000481	0.00164	CcSEcCtD
Histamine Phosphate—Rash—Imiquimod—skin cancer	0.00048	0.00164	CcSEcCtD
Histamine Phosphate—Dermatitis—Imiquimod—skin cancer	0.00048	0.00163	CcSEcCtD
Histamine Phosphate—Pneumonia—Docetaxel—skin cancer	0.000479	0.00163	CcSEcCtD
Histamine Phosphate—Headache—Imiquimod—skin cancer	0.000477	0.00162	CcSEcCtD
Histamine Phosphate—Anaemia—Fluorouracil—skin cancer	0.000476	0.00162	CcSEcCtD
Histamine Phosphate—Arthralgia—Temozolomide—skin cancer	0.000476	0.00162	CcSEcCtD
Histamine Phosphate—Myalgia—Temozolomide—skin cancer	0.000476	0.00162	CcSEcCtD
Histamine Phosphate—Infestation NOS—Docetaxel—skin cancer	0.000476	0.00162	CcSEcCtD
Histamine Phosphate—Infestation—Docetaxel—skin cancer	0.000476	0.00162	CcSEcCtD
Histamine Phosphate—Anxiety—Temozolomide—skin cancer	0.000474	0.00162	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000473	0.00161	CcSEcCtD
Histamine Phosphate—Discomfort—Temozolomide—skin cancer	0.00047	0.0016	CcSEcCtD
Histamine Phosphate—Decreased appetite—Bleomycin—skin cancer	0.00047	0.0016	CcSEcCtD
Histamine Phosphate—Renal failure—Docetaxel—skin cancer	0.000468	0.00159	CcSEcCtD
Histamine Phosphate—Dry mouth—Temozolomide—skin cancer	0.000466	0.00159	CcSEcCtD
Histamine Phosphate—Stomatitis—Docetaxel—skin cancer	0.000464	0.00158	CcSEcCtD
Histamine Phosphate—SLC22A3—lymph node—skin cancer	0.000464	0.0112	CbGeAlD
Histamine Phosphate—Pain—Bleomycin—skin cancer	0.000463	0.00158	CcSEcCtD
Histamine Phosphate—Leukopenia—Fluorouracil—skin cancer	0.000461	0.00157	CcSEcCtD
Histamine Phosphate—Confusional state—Temozolomide—skin cancer	0.00046	0.00157	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00046	0.00157	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Temozolomide—skin cancer	0.000456	0.00155	CcSEcCtD
Histamine Phosphate—Infection—Temozolomide—skin cancer	0.000453	0.00154	CcSEcCtD
Histamine Phosphate—Nausea—Imiquimod—skin cancer	0.000452	0.00154	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Temozolomide—skin cancer	0.000448	0.00152	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Temozolomide—skin cancer	0.000447	0.00152	CcSEcCtD
Histamine Phosphate—Convulsion—Fluorouracil—skin cancer	0.000446	0.00152	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Bleomycin—skin cancer	0.000446	0.00152	CcSEcCtD
Histamine Phosphate—Skin disorder—Temozolomide—skin cancer	0.000443	0.00151	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Temozolomide—skin cancer	0.000441	0.0015	CcSEcCtD
Histamine Phosphate—Chest pain—Fluorouracil—skin cancer	0.000439	0.00149	CcSEcCtD
Histamine Phosphate—Myalgia—Fluorouracil—skin cancer	0.000439	0.00149	CcSEcCtD
Histamine Phosphate—Decreased appetite—Dactinomycin—skin cancer	0.000439	0.00149	CcSEcCtD
Histamine Phosphate—Fatigue—Dactinomycin—skin cancer	0.000435	0.00148	CcSEcCtD
Histamine Phosphate—Anorexia—Temozolomide—skin cancer	0.000435	0.00148	CcSEcCtD
Histamine Phosphate—Discomfort—Fluorouracil—skin cancer	0.000433	0.00148	CcSEcCtD
Histamine Phosphate—Pain—Dactinomycin—skin cancer	0.000431	0.00147	CcSEcCtD
Histamine Phosphate—Urticaria—Bleomycin—skin cancer	0.00043	0.00146	CcSEcCtD
Histamine Phosphate—Body temperature increased—Bleomycin—skin cancer	0.000428	0.00146	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Docetaxel—skin cancer	0.000425	0.00145	CcSEcCtD
Histamine Phosphate—Confusional state—Fluorouracil—skin cancer	0.000424	0.00144	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Docetaxel—skin cancer	0.000421	0.00143	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Fluorouracil—skin cancer	0.00042	0.00143	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Docetaxel—skin cancer	0.00042	0.00143	CcSEcCtD
Histamine Phosphate—Infection—Fluorouracil—skin cancer	0.000418	0.00142	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Dactinomycin—skin cancer	0.000416	0.00142	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000416	0.00142	CcSEcCtD
Histamine Phosphate—CA4—lymph node—skin cancer	0.000413	0.00994	CbGeAlD
Histamine Phosphate—Insomnia—Temozolomide—skin cancer	0.000413	0.00141	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000413	0.00141	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Fluorouracil—skin cancer	0.000412	0.0014	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Fluorouracil—skin cancer	0.000412	0.0014	CcSEcCtD
Histamine Phosphate—Tachycardia—Fluorouracil—skin cancer	0.00041	0.0014	CcSEcCtD
Histamine Phosphate—Paraesthesia—Temozolomide—skin cancer	0.00041	0.0014	CcSEcCtD
Histamine Phosphate—HRH1—head—skin cancer	0.000408	0.00982	CbGeAlD
Histamine Phosphate—Dyspnoea—Temozolomide—skin cancer	0.000407	0.00139	CcSEcCtD
Histamine Phosphate—Dyspepsia—Temozolomide—skin cancer	0.000402	0.00137	CcSEcCtD
Histamine Phosphate—Anorexia—Fluorouracil—skin cancer	0.000401	0.00137	CcSEcCtD
Histamine Phosphate—Abdominal pain—Dactinomycin—skin cancer	0.000399	0.00136	CcSEcCtD
Histamine Phosphate—Body temperature increased—Dactinomycin—skin cancer	0.000399	0.00136	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Bleomycin—skin cancer	0.000399	0.00136	CcSEcCtD
Histamine Phosphate—Decreased appetite—Temozolomide—skin cancer	0.000397	0.00135	CcSEcCtD
Histamine Phosphate—Flushing—Docetaxel—skin cancer	0.000396	0.00135	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Docetaxel—skin cancer	0.000396	0.00135	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000394	0.00134	CcSEcCtD
Histamine Phosphate—Fatigue—Temozolomide—skin cancer	0.000393	0.00134	CcSEcCtD
Histamine Phosphate—Hypotension—Fluorouracil—skin cancer	0.000393	0.00134	CcSEcCtD
Histamine Phosphate—Pain—Temozolomide—skin cancer	0.00039	0.00133	CcSEcCtD
Histamine Phosphate—Constipation—Temozolomide—skin cancer	0.00039	0.00133	CcSEcCtD
Histamine Phosphate—Asthenia—Bleomycin—skin cancer	0.000388	0.00132	CcSEcCtD
Histamine Phosphate—Angiopathy—Docetaxel—skin cancer	0.000388	0.00132	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Docetaxel—skin cancer	0.000385	0.00131	CcSEcCtD
Histamine Phosphate—Chills—Docetaxel—skin cancer	0.000383	0.00131	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000383	0.0013	CcSEcCtD
Histamine Phosphate—Pruritus—Bleomycin—skin cancer	0.000383	0.0013	CcSEcCtD
Histamine Phosphate—Arrhythmia—Docetaxel—skin cancer	0.000382	0.0013	CcSEcCtD
Histamine Phosphate—Insomnia—Fluorouracil—skin cancer	0.00038	0.0013	CcSEcCtD
Histamine Phosphate—CYP3A4—female reproductive system—skin cancer	0.000378	0.00909	CbGeAlD
Histamine Phosphate—Paraesthesia—Fluorouracil—skin cancer	0.000378	0.00129	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Temozolomide—skin cancer	0.000376	0.00128	CcSEcCtD
Histamine Phosphate—Dyspnoea—Fluorouracil—skin cancer	0.000375	0.00128	CcSEcCtD
Histamine Phosphate—Mental disorder—Docetaxel—skin cancer	0.000374	0.00127	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Temozolomide—skin cancer	0.000373	0.00127	CcSEcCtD
Histamine Phosphate—CYP2D6—female reproductive system—skin cancer	0.000372	0.00894	CbGeAlD
Histamine Phosphate—Erythema—Docetaxel—skin cancer	0.000372	0.00127	CcSEcCtD
Histamine Phosphate—Malnutrition—Docetaxel—skin cancer	0.000372	0.00127	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Dactinomycin—skin cancer	0.000372	0.00127	CcSEcCtD
Histamine Phosphate—Dyspepsia—Fluorouracil—skin cancer	0.00037	0.00126	CcSEcCtD
Histamine Phosphate—Decreased appetite—Fluorouracil—skin cancer	0.000366	0.00124	CcSEcCtD
Histamine Phosphate—Dysgeusia—Docetaxel—skin cancer	0.000364	0.00124	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000363	0.00124	CcSEcCtD
Histamine Phosphate—Urticaria—Temozolomide—skin cancer	0.000363	0.00123	CcSEcCtD
Histamine Phosphate—Asthenia—Dactinomycin—skin cancer	0.000362	0.00123	CcSEcCtD
Histamine Phosphate—Body temperature increased—Temozolomide—skin cancer	0.000361	0.00123	CcSEcCtD
Histamine Phosphate—Abdominal pain—Temozolomide—skin cancer	0.000361	0.00123	CcSEcCtD
Histamine Phosphate—Back pain—Docetaxel—skin cancer	0.00036	0.00122	CcSEcCtD
Histamine Phosphate—Pain—Fluorouracil—skin cancer	0.00036	0.00122	CcSEcCtD
Histamine Phosphate—Muscle spasms—Docetaxel—skin cancer	0.000357	0.00122	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Fluorouracil—skin cancer	0.000346	0.00118	CcSEcCtD
Histamine Phosphate—Diarrhoea—Dactinomycin—skin cancer	0.000345	0.00118	CcSEcCtD
Histamine Phosphate—Vomiting—Bleomycin—skin cancer	0.000344	0.00117	CcSEcCtD
Histamine Phosphate—Anaemia—Docetaxel—skin cancer	0.000344	0.00117	CcSEcCtD
Histamine Phosphate—Rash—Bleomycin—skin cancer	0.000341	0.00116	CcSEcCtD
Histamine Phosphate—Dermatitis—Bleomycin—skin cancer	0.000341	0.00116	CcSEcCtD
Histamine Phosphate—SLC22A5—lymph node—skin cancer	0.000337	0.00811	CbGeAlD
Histamine Phosphate—Hypersensitivity—Temozolomide—skin cancer	0.000336	0.00115	CcSEcCtD
Histamine Phosphate—Urticaria—Fluorouracil—skin cancer	0.000334	0.00114	CcSEcCtD
Histamine Phosphate—Leukopenia—Docetaxel—skin cancer	0.000333	0.00113	CcSEcCtD
Histamine Phosphate—Body temperature increased—Fluorouracil—skin cancer	0.000332	0.00113	CcSEcCtD
Histamine Phosphate—Palpitations—Docetaxel—skin cancer	0.000329	0.00112	CcSEcCtD
Histamine Phosphate—Asthenia—Temozolomide—skin cancer	0.000327	0.00112	CcSEcCtD
Histamine Phosphate—Cough—Docetaxel—skin cancer	0.000324	0.00111	CcSEcCtD
Histamine Phosphate—Pruritus—Temozolomide—skin cancer	0.000323	0.0011	CcSEcCtD
Histamine Phosphate—Convulsion—Docetaxel—skin cancer	0.000322	0.0011	CcSEcCtD
Histamine Phosphate—Nausea—Bleomycin—skin cancer	0.000321	0.00109	CcSEcCtD
Histamine Phosphate—Hypertension—Docetaxel—skin cancer	0.000321	0.00109	CcSEcCtD
Histamine Phosphate—Vomiting—Dactinomycin—skin cancer	0.000321	0.00109	CcSEcCtD
Histamine Phosphate—Rash—Dactinomycin—skin cancer	0.000318	0.00108	CcSEcCtD
Histamine Phosphate—Arthralgia—Docetaxel—skin cancer	0.000317	0.00108	CcSEcCtD
Histamine Phosphate—Myalgia—Docetaxel—skin cancer	0.000317	0.00108	CcSEcCtD
Histamine Phosphate—Chest pain—Docetaxel—skin cancer	0.000317	0.00108	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000314	0.00107	CcSEcCtD
Histamine Phosphate—Diarrhoea—Temozolomide—skin cancer	0.000312	0.00106	CcSEcCtD
Histamine Phosphate—CYP2D6—head—skin cancer	0.000311	0.00747	CbGeAlD
Histamine Phosphate—Hypersensitivity—Fluorouracil—skin cancer	0.00031	0.00106	CcSEcCtD
Histamine Phosphate—Dry mouth—Docetaxel—skin cancer	0.00031	0.00105	CcSEcCtD
Histamine Phosphate—Confusional state—Docetaxel—skin cancer	0.000306	0.00104	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Docetaxel—skin cancer	0.000303	0.00103	CcSEcCtD
Histamine Phosphate—Dizziness—Temozolomide—skin cancer	0.000302	0.00103	CcSEcCtD
Histamine Phosphate—Infection—Docetaxel—skin cancer	0.000301	0.00103	CcSEcCtD
Histamine Phosphate—Nausea—Dactinomycin—skin cancer	0.0003	0.00102	CcSEcCtD
Histamine Phosphate—Shock—Docetaxel—skin cancer	0.000299	0.00102	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Docetaxel—skin cancer	0.000298	0.00101	CcSEcCtD
Histamine Phosphate—Pruritus—Fluorouracil—skin cancer	0.000297	0.00101	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Docetaxel—skin cancer	0.000297	0.00101	CcSEcCtD
Histamine Phosphate—Tachycardia—Docetaxel—skin cancer	0.000296	0.00101	CcSEcCtD
Histamine Phosphate—Skin disorder—Docetaxel—skin cancer	0.000295	0.001	CcSEcCtD
Histamine Phosphate—Vomiting—Temozolomide—skin cancer	0.00029	0.000988	CcSEcCtD
Histamine Phosphate—Anorexia—Docetaxel—skin cancer	0.000289	0.000985	CcSEcCtD
Histamine Phosphate—Rash—Temozolomide—skin cancer	0.000288	0.00098	CcSEcCtD
Histamine Phosphate—Diarrhoea—Fluorouracil—skin cancer	0.000288	0.00098	CcSEcCtD
Histamine Phosphate—Dermatitis—Temozolomide—skin cancer	0.000287	0.000979	CcSEcCtD
Histamine Phosphate—HRH1—lymph node—skin cancer	0.000286	0.00688	CbGeAlD
Histamine Phosphate—Headache—Temozolomide—skin cancer	0.000286	0.000974	CcSEcCtD
Histamine Phosphate—Hypotension—Docetaxel—skin cancer	0.000284	0.000966	CcSEcCtD
Histamine Phosphate—Dizziness—Fluorouracil—skin cancer	0.000278	0.000947	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000276	0.000942	CcSEcCtD
Histamine Phosphate—Insomnia—Docetaxel—skin cancer	0.000274	0.000935	CcSEcCtD
Histamine Phosphate—Paraesthesia—Docetaxel—skin cancer	0.000273	0.000928	CcSEcCtD
Histamine Phosphate—Nausea—Temozolomide—skin cancer	0.000271	0.000923	CcSEcCtD
Histamine Phosphate—Dyspnoea—Docetaxel—skin cancer	0.000271	0.000921	CcSEcCtD
Histamine Phosphate—Vomiting—Fluorouracil—skin cancer	0.000267	0.00091	CcSEcCtD
Histamine Phosphate—Dyspepsia—Docetaxel—skin cancer	0.000267	0.00091	CcSEcCtD
Histamine Phosphate—Rash—Fluorouracil—skin cancer	0.000265	0.000903	CcSEcCtD
Histamine Phosphate—Dermatitis—Fluorouracil—skin cancer	0.000265	0.000902	CcSEcCtD
Histamine Phosphate—Decreased appetite—Docetaxel—skin cancer	0.000264	0.000898	CcSEcCtD
Histamine Phosphate—Headache—Fluorouracil—skin cancer	0.000263	0.000897	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000262	0.000892	CcSEcCtD
Histamine Phosphate—Fatigue—Docetaxel—skin cancer	0.000262	0.000891	CcSEcCtD
Histamine Phosphate—Constipation—Docetaxel—skin cancer	0.00026	0.000884	CcSEcCtD
Histamine Phosphate—Pain—Docetaxel—skin cancer	0.00026	0.000884	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Docetaxel—skin cancer	0.00025	0.000852	CcSEcCtD
Histamine Phosphate—Nausea—Fluorouracil—skin cancer	0.00025	0.000851	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Docetaxel—skin cancer	0.000248	0.000845	CcSEcCtD
Histamine Phosphate—Abdominal pain—Docetaxel—skin cancer	0.00024	0.000817	CcSEcCtD
Histamine Phosphate—Body temperature increased—Docetaxel—skin cancer	0.00024	0.000817	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Docetaxel—skin cancer	0.000224	0.000761	CcSEcCtD
Histamine Phosphate—Asthenia—Docetaxel—skin cancer	0.000218	0.000742	CcSEcCtD
Histamine Phosphate—Pruritus—Docetaxel—skin cancer	0.000215	0.000731	CcSEcCtD
Histamine Phosphate—Diarrhoea—Docetaxel—skin cancer	0.000208	0.000707	CcSEcCtD
Histamine Phosphate—Dizziness—Docetaxel—skin cancer	0.000201	0.000683	CcSEcCtD
Histamine Phosphate—Vomiting—Docetaxel—skin cancer	0.000193	0.000657	CcSEcCtD
Histamine Phosphate—Rash—Docetaxel—skin cancer	0.000191	0.000652	CcSEcCtD
Histamine Phosphate—Dermatitis—Docetaxel—skin cancer	0.000191	0.000651	CcSEcCtD
Histamine Phosphate—Headache—Docetaxel—skin cancer	0.00019	0.000647	CcSEcCtD
Histamine Phosphate—Nausea—Docetaxel—skin cancer	0.00018	0.000614	CcSEcCtD
